Safely and effectively relieving a patient’s pain has been an elusive goal for doctors everywhere because painkillers are notorious for their addictive nature or unforeseen side effects. That’s why doctors and patients alike were intrigued when a new drug named OxyContin came out in the 1990s. It was touted as both effective and less addictive than other drugs currently on the market.
However, more than 20 years after it was approved by the U.S. Food and Drug Administration, OxyContin has become a key culprit in the deadly opioid epidemic now plaguing the United States.
OxyContin has made drugmaker Purdue Pharma more than $35 billion in sales over the last two decades thanks to aggressive marketing tactics and potentially illegal practices. Now, states across the country and victims of OxyContin addiction are filing lawsuits against Purdue Pharma.